Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | GERBRANDY Gerben-Jan (ALDE) | RÜBIG Paul (PPE), AYALA SENDER Inés (S&D), STAES Bart (Verts/ALE), BRADBOURN Philip (ECR), SØNDERGAARD Søren Bo (GUE/NGL), ANDREASEN Marta (EFD), EHRENHAUSER Martin (NI) |
Opinion | ENVI | ||
Opinion | ITRE |
Activites
- 2013/11/16 Final act published in Official Journal
-
2013/04/17
Decision by Parliament, 1st reading/single reading
-
T7-0169/2013
summary
The European Parliament adopted a decision on discharge to be granted to the Executive Director of the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines (IMI) for the financial year 2011. The vote on the decision to grant discharge covers the closure of the accounts (in accordance with Annex VI, Article 5(1) of the European Parliament’s Rules of Procedure). Noting that the Court of Auditors stated that it has obtained reasonable assurances that the annual accounts of the Joint Undertaking for the financial year 2011 are reliable but that it had delivered a qualified opinion on the legality and the regularity of the transactions underlying the Undertaking’s accounts, Parliament approved the closure of the accounts. It, however, adopted a series of recommendations that need to be taken into account when the discharge is granted, in addition to the general recommendations that appear in the draft resolution on performance, financial management and control of EU agencies. Financing, budget and financial management: the maximum contribution for the period of 10 years from the Union to the Joint Undertaking is EUR 1 billion to be paid from the budget of the Seventh Research Framework Programme. Parliament notes that the budget of the Joint Undertaking for the financial year 2011 and the implementation plan were adopted by the Governing Board very late and that this delayed the launch of the call for proposals and, for the entire first quarter of the year, the Joint Undertaking was obliged to use provisional twelfths budget rule to make payments; Implementation rate of appropriations and carryovers: Parliament reiterates its concern about the low implementation rate of the commitment appropriations available for research activities and express, once again, their concern about the low implementation rate of the Joint Undertaking’s budget. It calls for a detailed progress report on those shortcomings. Qualified opinion of the Court of Auditors: Parliament is concerned that the Joint Undertaking annual accounts received a qualified opinion from the Court of Auditors on the legality and the regularity of the transactions underlying those accounts on the grounds that the error rate resulting from the ex-post audits was 6.84%. It awaits the agreement between the Court and the Joint Undertaking on an audit methodology that for the same ex-post audits delivers the same results. EFPIA: Parliament is surprised to learn that the provisions of the grant agreement do not recognise the right of the Court of Auditors to audit the in-kind contributions of EFPIA companies although they are recorded in the financial statements of the Joint Undertaking and are estimated at EUR 1 000 million over the lifetime of the Joint Undertaking. Lastly, Parliament also makes a series of observations as regards the Joint Undertaking’s procedures for calls for proposals, its internal control systems, its annual activity report, as well as other management matters. Parliament invites the Court of Auditors to provide, within a reasonable deadline, a special report to Parliament on common issues which occur due to the nature of the joint undertakings in order to ensure their added value and efficient execution of Union research, technological development and demonstration programmes. It further notes that the same report should include an assessment of the effectiveness of the joint undertakings' establishment and structure.
-
T7-0169/2013
summary
- 2013/04/16 Debate in Parliament
-
2013/03/21
Committee report tabled for plenary, single reading
-
A7-0088/2013
summary
The Committee on Budgetary Control adopted the report by Gerben-Jan GERBRANDY (ADLE, NL) on discharge to be granted to the Executive Director of the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines in respect of the implementation of the budget of the Joint Undertaking for the financial year 2011. Noting that the Court of Auditors stated that it has obtained reasonable assurances that the annual accounts of the Joint Undertaking for the financial year 2011 are reliable but has delivered a qualified opinion on the legality and the regularity of the transactions underlying the Joint Undertaking's accounts, Members approve the closure of the Joint Undertaking’s accounts. However, they make a number of recommendations that need to be taken into account when the discharge is granted, in addition to the general recommendations that appear in the draft resolution on performance, financial management and control of EU agencies: Financing, budget and financial management: the maximum contribution for the period of 10 years from the Union to the Joint Undertaking is EUR 1 billion to be paid from the budget of the Seventh Research Framework Programme. Members note that the budget of the Joint Undertaking for the financial year 2011 and the implementation plan were adopted by the Governing Board very late and that this delayed the launch of the call for proposals and, for the entire first quarter of the year, the Joint Undertaking was obliged to use provisional twelfths budget rule to make payments; Implementation rate of appropriations and carryovers: Members reiterate their concern about the low implementation rate of the commitment appropriations available for research activities and express, once again, their concern about the low implementation rate of the Joint Undertaking’s budget. They call for a detailed progress report on those shortcomings. Qualified opinion of the Court of Auditors: Members are concerned that the Joint Undertaking annual accounts received a qualified opinion from the Court of Auditors on the legality and the regularity of the transactions underlying those accounts on the grounds that the error rate resulting from the ex-post audits was 6.84%. They await the agreement between the Court and the Joint Undertaking on an audit methodology that for the same ex-post audits delivers the same results. Lastly, Members made a series of observations as regards the Joint Undertaking’s procurement system, its control system and its internal audit system, the weaknesses in its annual activity report and other questions linked to the management of this Joint Undertaking. They reiterate their invitation for the Court of Auditors to provide, within a reasonable deadline, a special report to Parliament on common issues due to the nature of the joint undertakings in order to ensure their added value and efficient execution of Union research, technological development and demonstration programmes. They call for that report should include an assessment of the effectiveness of the joint undertakings' establishment and structure.
-
A7-0088/2013
summary
-
2013/03/19
Vote in committee, 1st reading/single reading
-
2012/09/13
Committee referral announced in Parliament, 1st reading/single reading
-
2012/07/25
Non-legislative basic document published
-
COM(2012)0436
summary
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2011, as part of the 2011 discharge procedure. Analysis of the accounts of the Innovative Medicines Initiative Joint Undertaking (IMI). CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2011 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the Innovative Medicines Initiative Joint Undertaking (IMI). In 2011, the tasks and budget of this agency were as follows: description of the tasks of the Joint Undertaking: the IMI Joint undertaking, which is located in Brussels, was set up in 2007 by Council Regulation (EC) No 73/2008 for a period of 10 years. Its main task is to improve significantly the efficiency, effectiveness and safety of the drug development process; budget of the Joint Undertaking for the 2011 financial year: the maximum EU contribution to the IMI Joint Undertaking to cover running costs and research activities is EUR 1 billion to be paid from the budget of the Seventh Research Framework Programme. The complete version of the Agency's final accounts for 2011 may be found at the following address: http://www.imi.europa.eu/content/budget-0
- DG {'url': 'http://ec.europa.eu/dgs/budget/', 'title': 'Budget'}, ŠEMETA Algirdas
-
COM(2012)0436
summary
Documents
- Non-legislative basic document published: COM(2012)0436
- Committee report tabled for plenary, single reading: A7-0088/2013
- Debate in Parliament: Debate in Parliament
- Decision by Parliament, 1st reading/single reading: T7-0169/2013
- : Decision 2013/622
- : OJ L 308 16.11.2013, p. 0357
Amendments | Dossier |
15 |
2012/2219(DEC)
2013/02/27
CONT
15 amendments...
Amendment 1 #
Proposal for a decision 1 Paragraph 1 1.
Amendment 10 #
Motion for a resolution Paragraph 3 3. Regrets therefore that commitment appropriations amounting to 117 million euro and payment appropriations amounting to 65 million euro not used in the financial year 2010 were carried over to 2011 and commitment appropriations amounting to 62 million euro and payment appropriations amounting to 11 million
Amendment 11 #
Motion for a resolution Paragraph 4 a (new) 4a. Calls therefore for a detailed progress report which makes specific proposals for a gradual reduction in the error rate;
Amendment 12 #
Motion for a resolution Paragraph 7 7. Points out that the Court of auditors reports significant progress regarding internal control systems during 2011 however, further work is needed to establish and document the budget and accounting procedures and related controls and
Amendment 13 #
Motion for a resolution Paragraph 13 13.
Amendment 14 #
Motion for a resolution Paragraph 14 14. Is surprised to learn that the provisions of the grant agreement do not recognise the right of the Court of Auditors to audit the in-kind contributions of EFPIA companies although they are recorded in IMI's financial statements and are estimated at one billion euro over IMI's lifetime; notes that in-kind contribution is audited by IMI JU in line with Article 12 (4) and (5) of the Council Regulation and that the advice of the EC is being sought by IMI JU on the rights of the ECA to audit in- kind contributions of EFPIA companies.
Amendment 15 #
Motion for a resolution Paragraph 18 18. Reiterates its invitation for the Court of Auditors to provide, within a reasonable deadline, a special report to Parliament on
Amendment 2 #
Proposal for a decision 1 Paragraph 1 1.
Amendment 3 #
Proposal for a decision 1 Paragraph 1 1.
Amendment 4 #
Proposal for a decision 1 Paragraph 1 1.
Amendment 5 #
Proposal for a decision 1 Paragraph 1 1.
Amendment 6 #
Proposal for a decision 2 Paragraph 1 1.
Amendment 7 #
Proposal for a decision 2 Paragraph 1 1.
Amendment 8 #
Proposal for a decision 2 Paragraph 1 1.
Amendment 9 #
Motion for a resolution Paragraph 2 2. Is concerned that the implementation rate for the 159 million euro commitment appropriations available for research activities was 66 % and it was implemented through a global commitment covering the fourth call for proposals; reiterates its concerned about the low implementation rate of the budget and, moreover, about the underlying activities of the Joint Undertaking
source: PE-506.006
|
History
(these mark the time of scraping, not the official date of the change)
activities |
|
commission |
|
committees/0 |
|
committees/0 |
|
committees/1 |
|
committees/1 |
|
committees/2 |
|
committees/2 |
|
docs |
|
events |
|
links |
|
other |
|
procedure/dossier_of_the_committee |
Old
CONT/7/10581New
|
procedure/final/url |
Old
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32013D0622New
https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32013D0622 |
procedure/subject |
Old
New
|
activities/0/docs/0/celexid |
CELEX:52012DC0436:EN
|
activities/0/docs/0/celexid |
CELEX:52012DC0436:EN
|
activities/0/type |
Old
Non-legislative basic documentNew
Non-legislative basic document published |
activities/1/committees |
|
activities/1/date |
Old
2013-02-27T00:00:00New
2012-09-13T00:00:00 |
activities/1/docs |
|
activities/1/type |
Old
Amendments tabled in committeeNew
Committee referral announced in Parliament, 1st reading/single reading |
activities/2 |
|
activities/2/body |
Old
CSLNew
EP |
activities/2/committees |
|
activities/2/date |
Old
2013-02-01T00:00:00New
2013-03-19T00:00:00 |
activities/2/docs |
|
activities/2/type |
Old
Document attached to the procedureNew
Vote in committee, 1st reading/single reading |
activities/3 |
|
activities/5/type |
Old
Text adopted by Parliament, single readingNew
Decision by Parliament, 1st reading/single reading |
activities/6 |
|
activities/6/body |
EP
|
activities/6/committees |
|
activities/6/date |
Old
2012-09-13T00:00:00New
2013-11-16T00:00:00 |
activities/6/docs |
|
activities/6/text |
|
activities/6/type |
Old
Committee referral announced in Parliament, 1st reading/single readingNew
Final act published in Official Journal |
activities/10 |
|
committees/0/rapporteur/0/mepref |
Old
4de185240fb8127435bdbe92New
4f1ac83bb819f25efd0000d5 |
committees/0/shadows/0/group |
Old
EPPNew
PPE |
committees/0/shadows/0/mepref |
Old
4de187df0fb8127435bdc267New
4f1adae9b819f207b3000099 |
committees/0/shadows/1/mepref |
Old
4de182da0fb8127435bdbb40New
4f1ac616b819f25efd00001b |
committees/0/shadows/2/mepref |
Old
4de188650fb8127435bdc331New
4f1adb8fb819f207b30000cf |
committees/0/shadows/3/mepref |
Old
4de183420fb8127435bdbbd0New
4f1ac68cb819f25efd000049 |
committees/0/shadows/4/mepref |
Old
4de1888a0fb8127435bdc36aNew
4f1adb84b819f207b30000cb |
committees/0/shadows/5/mepref |
Old
4de182e40fb8127435bdbb4bNew
4f1ac5e7b819f25efd00000a |
committees/0/shadows/6/mepref |
Old
4de1847f0fb8127435bdbd9fNew
4f1ac7b8b819f25efd0000a5 |
activities/10 |
|
procedure/final |
|
procedure/stage_reached |
Old
Procedure completed, awaiting publication in Official JournalNew
Procedure completed |
activities/0/docs/0/celexid |
CELEX:52012DC0436:EN
|
activities/8/docs |
|
activities/0/docs/0/celexid |
CELEX:52012DC0436:EN
|
activities/4/docs/0/type |
Old
Supplementary non-legislative basic documentNew
Document attached to the procedure |
activities/4/type |
Old
Supplementary non-legislative basic documentNew
Document attached to the procedure |
activities/8/docs |
|
activities/8/docs |
|
procedure/Modified legal basis |
$procedure.legalBasisListProposed
|
procedure/legal_basis |
|
procedure/?!oeil-proposed_legal_basis!? |
$procedure.legalBasisListProposed
|
procedure/Modified legal basis |
$procedure.legalBasisListProposed
|
activities/4/docs/0/type |
Old
Document attached to the procedureNew
Supplementary non-legislative basic document |
activities/4/type |
Old
Document attached to the procedureNew
Supplementary non-legislative basic document |
activities/8/docs |
|
procedure/?!oeil-proposed_legal_basis!? |
$procedure.legalBasisListProposed
|
procedure/legal_basis |
|
activities/8/docs |
|
activities/9/docs/0/text |
|
activities/8/type |
Old
Indicative plenary sitting date, 1st reading/single readingNew
Debate in Parliament |
activities/9 |
|
procedure/stage_reached |
Old
Awaiting Parliament 1st reading / single reading / budget 1st stageNew
Procedure completed, awaiting publication in Official Journal |
activities/7/docs/0/text/0 |
Old
The Committee on Budgetary Control adopted the report by Gerben-Jan GERBRANDY (ADLE, NL) on discharge to be granted to the Executive Director of the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines in respect of the implementation of the budget of the Joint Undertaking for the financial year 2011. Noting that the Court of Auditors stated that it has obtained reasonable assurances that the annual accounts of the Joint Undertaking for the financial year 2011 are reliable but has delivered a qualified opinion on the legality and the regularity of the transactions underlying the Joint Undertaking's accounts, Members approve the closure of the Joint Undertakings accounts. However, they make a number of recommendations that need to be taken into account when the discharge is granted, in addition to the general recommendations that appear in the draft resolution on performance, financial management and control of EU agencies:
Lastly, Members made a series of observations as regards the Joint Undertakings procurement system, its control system and its internal audit system, the weaknesses in its annual activity report and other questions linked to the management of this Joint Undertaking. They reiterate their invitation for the Court of Auditors to provide, within a reasonable deadline, a special report to Parliament on common issues due to the nature of the joint undertakings in order to ensure their added value and efficient execution of Union research, technological development and demonstration programmes. They call for that report should include an assessment of the effectiveness of the joint undertakings' establishment and structure. New
The Committee on Budgetary Control adopted the report by Gerben-Jan GERBRANDY (ADLE, NL) on discharge to be granted to the Executive Director of the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines in respect of the implementation of the budget of the Joint Undertaking for the financial year 2011. Noting that the Court of Auditors stated that it has obtained reasonable assurances that the annual accounts of the Joint Undertaking for the financial year 2011 are reliable but has delivered a qualified opinion on the legality and the regularity of the transactions underlying the Joint Undertaking's accounts, Members approve the closure of the Joint Undertakings accounts. However, they make a number of recommendations that need to be taken into account when the discharge is granted, in addition to the general recommendations that appear in the draft resolution on performance, financial management and control of EU agencies:
Lastly, Members made a series of observations as regards the Joint Undertakings procurement system, its control system and its internal audit system, the weaknesses in its annual activity report and other questions linked to the management of this Joint Undertaking. They reiterate their invitation for the Court of Auditors to provide, within a reasonable deadline, a special report to Parliament on common issues due to the nature of the joint undertakings in order to ensure their added value and efficient execution of Union research, technological development and demonstration programmes. They call for that report should include an assessment of the effectiveness of the joint undertakings' establishment and structure. |
activities/7/docs/0/text |
|
activities/7/docs/0/url |
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2013-88&language=EN
|
activities/7 |
|
activities/6/committees |
|
activities/6/type |
Old
Vote scheduled in committee, 1st reading/single readingNew
Vote in committee, 1st reading/single reading |
activities/4/docs/0/type |
Old
Supplementary non-legislative basic documentNew
Document attached to the procedure |
activities/4/type |
Old
Supplementary non-legislative basic documentNew
Document attached to the procedure |
activities/4/docs/0/text |
|
activities/4/docs/0/type |
Old
Document attached to the procedureNew
Supplementary non-legislative basic document |
activities/4/type |
Old
Document attached to the procedureNew
Supplementary non-legislative basic document |
activities/5/docs/0/url |
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE506.006
|
activities/0/docs/0/celexid |
CELEX:52012DC0436:EN
|
activities/2/docs/1/text |
|
activities/5 |
|
activities/0/docs/0/celexid |
CELEX:52012DC0436:EN
|
activities/0/docs/0/text/0 |
Old
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2011, as part of the 2011 discharge procedure. Analysis of the accounts of the Innovative Medicines Initiative Joint Undertaking (IMI). CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2011 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the Innovative Medicines Initiative Joint Undertaking (IMI). In 2011, the tasks and budget of this agency were as follows:
The complete version of the Agency's final accounts for 2011 may be found at the following address: http://www.imi.europa.eu/content/budget-0 New
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2011, as part of the 2011 discharge procedure. Analysis of the accounts of the Innovative Medicines Initiative Joint Undertaking (IMI). CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2011 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the Innovative Medicines Initiative Joint Undertaking (IMI). In 2011, the tasks and budget of this agency were as follows:
The complete version of the Agency's final accounts for 2011 may be found at the following address: http://www.imi.europa.eu/content/budget-0 |
activities/4 |
|
activities/2 |
|
activities/2/docs/0/url |
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE497.955
|
activities/2 |
|
activities/0 |
|
activities/0/body |
Old
EPNew
EC |
activities/0/commission |
|
activities/0/date |
Old
2013-05-09T00:00:00New
2012-07-25T00:00:00 |
activities/0/docs |
|
activities/0/type |
Old
EP 1R PlenaryNew
Non-legislative basic document |
activities/1 |
|
activities/3 |
|
activities/7 |
|
activities/2/committees/0/shadows/1 |
|
committees/0/shadows/1 |
|
activities/1/docs/0/url |
Old
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2012&nu_doc=436New
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2012/0436/COM_COM(2012)0436_EN.pdf |
activities/5 |
|
activities/6/type |
Old
Indicative plenary sitting date, 1st reading/single readingNew
EP 1R Plenary |
activities/7 |
|
activities/1/docs/0/celexid |
CELEX:52012DC0436:EN
|
activities/1/docs/0/text |
|
activities/2/committees/0/shadows/1 |
|
activities/2/committees/0/shadows/2/mepref |
Old
4de185660fb8127435bdbeeeNew
4de182da0fb8127435bdbb40 |
activities/2/committees/0/shadows/2/name |
Old
HERCZOG EditNew
AYALA SENDER Inés |
committees/0/shadows/1 |
|
committees/0/shadows/2/mepref |
Old
4de185660fb8127435bdbeeeNew
4de182da0fb8127435bdbb40 |
committees/0/shadows/2/name |
Old
HERCZOG EditNew
AYALA SENDER Inés |
activities/3 |
|
activities/2/committees/0/date |
2012-02-29T00:00:00
|
activities/2/committees/0/rapporteur |
|
activities/2/committees/0/shadows |
|
activities/3 |
|
committees/0/date |
2012-02-29T00:00:00
|
committees/0/rapporteur |
|
committees/0/shadows |
|
activities |
|
committees |
|
links |
|
other |
|
procedure |
|